Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Metronidazole
Drug ID BADD_D01449
Description Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics.[L3754] It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections.[A181036,A18039] Metronidazole has been used as an antibiotic for several decades[L7429], with added antiparasitic properties that set it apart from many other antibacterial drugs, allowing it to treat a wide variety of infections. It is available in capsule form, tablet form, and topical form, and suppository preparations for the treatment of various infections.
Indications and Usage Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis[L7432], certain types of amebiasis, and various anaerobic infections.[A181057] The above anaerobic infections may occur on the skin and skin structures, the abdomen, the heart, reproductive organs, central nervous system, and the respiratory system. Some may also be present in the bloodstream in cases of septicemia. Common infections treated by metronidazole are Bacteroides species infections, Clostridium infections, and Fusobacterium infections, as well as Peptococcus and Peptostreptococcus infections.[L3754] It is also used off-label in the treatment of Crohn's disease and rosacea, as a prophylactic agent after surgery[A181039], and in the treatment of Helicobacter pylori infection.[A181045] It has also been studied in the prevention of preterm births and to treat periodontal disease.[A1391,A181078]
Marketing Status approved
ATC Code A01AB17; D06BX01; G01AF01; J01XD01; P01AB01
DrugBank ID DB00916
KEGG ID D00409
MeSH ID D008795
PubChem ID 4173
TTD Drug ID D0A2ZX
NDC Product Code 80830-2465; 0904-7156; 23155-652; 50090-0211; 50090-4809; 50111-333; 51407-372; 62332-018; 66993-962; 67296-1366; 68071-2549; 0409-0152; 68180-684; 68682-455; 69292-208; 70518-0013; 70518-0539; 70518-2663; 70518-3042; 70771-1834; 71335-1775; 46708-428; 46708-429; 0187-5202; 50090-0212; 50090-0214; 50090-5691; 51407-376; 60687-550; 63629-1388; 63629-8731; 68788-7815; 70518-3265; 72578-008; 72578-129; 0713-0633; 0904-7126; 38779-0146; 62991-1685; 25021-131; 29300-227; 45802-139; 46708-435; 50090-5687; 51672-4164; 0264-5535; 55154-8190; 55700-909; 0299-3836; 0338-9541; 63187-035; 63629-7940; 64380-780; 64980-235; 66993-936; 68071-2806; 70518-1240; 70518-3110; 71335-1681; 54348-740; 60687-526; 62332-016; 63187-827; 66993-960; 68071-2809; 68071-5283; 68462-184; 70518-2305; 70518-2814; 70934-813; 71209-063; 71335-1609; 71335-1703; 71335-1838; 72578-007; 16714-557; 45865-717; 50090-5787; 51655-441; 55700-298; 61919-032; 62332-017; 67457-697; 68001-364; 68180-683; 72789-007; 72789-195; 15955-388; 16571-664; 0115-1474; 43063-738; 0168-0383; 50090-5688; 50268-534; 0245-0860; 53002-2478; 58118-0527; 0299-3820; 0338-1055; 64980-236; 65862-694; 67296-1283; 0404-9991; 68071-2251; 0409-7811; 68788-8230; 70518-0090; 70882-131; 0781-7077; 0781-7080; 51927-1449; 53747-007; 60592-427; 68981-034; 23155-651; 53002-2470; 0299-3838; 60760-539; 61919-499; 63629-1386; 63629-7916; 64380-779; 68788-7955; 70518-1536; 70518-3073; 71335-0358; 71335-1922; 0713-0575; 0713-0637; 49452-4726; 49964-0002; 51552-0038; 43063-719; 50090-5768; 50111-334; 50268-535; 51672-4116; 52584-811; 53002-7341; 63629-8680; 68083-373; 69043-005; 70518-0797; 70882-130; 71335-0858; 72789-011; 0642-7466; 73473-303; 0713-0574; 82982-039; 0395-8115; 15955-389; 21922-039; 47335-993; 50090-0213; 50090-5249; 51655-974; 54348-745; 60760-336; 67296-1747; 69043-004; 70518-0324; 70934-970; 71209-062; 72789-005; 16571-665; 29300-226; 46708-021; 53002-7340; 60760-664; 61919-363; 62332-630; 63187-511; 65862-695; 66993-961; 68001-365; 68071-2280; 68071-2288; 68071-2551; 68071-3039; 69292-207; 70518-0058; 70518-0088; 70518-1241; 70934-956; 0168-0275; 0168-0323; 50090-0201; 50090-2126; 51672-4215; 53002-2471; 0025-1942
UNII 140QMO216E
Synonyms Metronidazole | 2-Methyl-5-nitroimidazole-1-ethanol | 2 Methyl 5 nitroimidazole 1 ethanol | Satric | Trichazol | Trichopol | Trivazol | Metronidazole Phosphoester | Vagilen | Bayer 5360 | Metronidazole Phosphate | Danizol | Flagyl | Gineflavir | Metric | Metrodzhil | MetroGel | Metrogyl | Metronidazole Hydrochloride | Metronidazole Monohydrochloride | Clont
Chemical Information
Molecular Formula C6H9N3O3
CAS Registry Number 443-48-1
SMILES CC1=NC=C(N1CCO)[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Central nervous system lesion17.02.10.0110.000197%Not Available
Systemic inflammatory response syndrome24.06.03.008; 10.02.01.008; 08.01.05.0050.000026%Not Available
Enterocutaneous fistula23.07.04.017; 07.11.05.0050.000039%Not Available
Conjunctival hyperaemia06.04.01.0040.000026%Not Available
Oscillopsia06.02.06.0090.000066%Not Available
Ear discomfort04.03.01.005--Not Available
Eye pruritus06.04.05.0060.000053%Not Available
Ocular discomfort06.08.03.0080.000039%Not Available
Lymphatic disorder01.09.01.003--Not Available
Oedematous pancreatitis07.18.01.0060.000026%Not Available
Deafness bilateral04.02.01.0070.000118%Not Available
Oral pruritus07.05.05.0020.000026%Not Available
Musculoskeletal stiffness15.03.05.0270.000399%Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Organ failure08.01.03.0410.000026%Not Available
Allodynia17.02.07.0170.000026%Not Available
Type IV hypersensitivity reaction10.01.03.0220.000207%Not Available
Vanishing bile duct syndrome09.02.03.0030.000026%Not Available
Skin burning sensation23.03.03.021; 17.02.06.0090.000244%Not Available
Cerebral disorder17.02.10.0170.000039%Not Available
Foetal death18.01.02.003; 08.04.01.0110.000026%
Haemorrhage24.07.01.0020.003555%Not Available
Vulvovaginal pruritus23.03.12.009; 21.08.02.0040.000026%Not Available
Peripheral sensorimotor neuropathy17.09.03.0090.000092%Not Available
Gaze palsy17.02.05.044; 06.05.02.0140.000053%Not Available
Loss of proprioception17.02.07.0190.000026%Not Available
Hypoaesthesia oral07.05.05.003; 17.02.06.0210.000137%Not Available
Paraesthesia oral07.05.05.035; 17.02.06.0080.000168%Not Available
Cognitive disorder19.21.02.001; 17.03.03.0030.000144%
Toxic skin eruption12.03.01.073; 23.03.05.003; 10.01.01.0080.000092%Not Available
The 16th Page    First    Pre   16 17 18 19 20    Next   Last    Total 21 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene